In March 2025, the company announced new options for just a immediate-to-client giving of its Wegovy weight loss drug. The company founded a different pharmacy, called NovoCare, which might demand buyers $499 per month for access to the drug, below 50 percent the cost of the drug as a result of other pharmaceutical distribution networks.[fifty thre